Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colorectal Neoplasms | 6 | 2015 | 82 | 0.670 |
Why?
|
| Liver | 3 | 2008 | 173 | 0.550 |
Why?
|
| Colonoscopy | 5 | 2015 | 51 | 0.410 |
Why?
|
| Early Detection of Cancer | 5 | 2015 | 79 | 0.400 |
Why?
|
| Coffee | 1 | 2006 | 4 | 0.280 |
Why?
|
| Alanine Transaminase | 1 | 2006 | 21 | 0.280 |
Why?
|
| Caffeine | 1 | 2006 | 64 | 0.270 |
Why?
|
| Body Constitution | 1 | 2004 | 3 | 0.260 |
Why?
|
| Vitamin D Deficiency | 1 | 2004 | 10 | 0.250 |
Why?
|
| Fatty Liver | 1 | 2004 | 30 | 0.250 |
Why?
|
| Obesity | 2 | 2004 | 291 | 0.250 |
Why?
|
| Vitamin D | 1 | 2004 | 31 | 0.250 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2004 | 1 | 0.250 |
Why?
|
| Liver Failure | 1 | 2004 | 11 | 0.240 |
Why?
|
| Peptide Hormones | 1 | 2003 | 3 | 0.240 |
Why?
|
| Dietary Supplements | 1 | 2004 | 53 | 0.240 |
Why?
|
| Leptin | 1 | 2003 | 22 | 0.240 |
Why?
|
| Diagnostic Errors | 2 | 2014 | 40 | 0.240 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2015 | 132 | 0.240 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2003 | 14 | 0.230 |
Why?
|
| Energy Metabolism | 1 | 2003 | 52 | 0.230 |
Why?
|
| Immune System | 1 | 2003 | 20 | 0.230 |
Why?
|
| Plant Extracts | 2 | 2008 | 16 | 0.230 |
Why?
|
| Enteral Nutrition | 1 | 2003 | 49 | 0.230 |
Why?
|
| Perioperative Care | 1 | 2003 | 52 | 0.220 |
Why?
|
| Adenomatous Polyps | 2 | 2013 | 3 | 0.220 |
Why?
|
| Colonic Polyps | 2 | 2013 | 23 | 0.220 |
Why?
|
| Celiac Disease | 1 | 2002 | 10 | 0.220 |
Why?
|
| Adenoma | 2 | 2013 | 42 | 0.210 |
Why?
|
| DNA Methylation | 2 | 2013 | 124 | 0.210 |
Why?
|
| Colonic Neoplasms | 1 | 2002 | 66 | 0.200 |
Why?
|
| Biomarkers, Tumor | 2 | 2013 | 175 | 0.200 |
Why?
|
| Calcium | 2 | 2004 | 491 | 0.200 |
Why?
|
| Pain | 1 | 2004 | 391 | 0.200 |
Why?
|
| Humans | 21 | 2015 | 29337 | 0.170 |
Why?
|
| Mass Screening | 2 | 2015 | 177 | 0.140 |
Why?
|
| Adenocarcinoma | 2 | 2014 | 189 | 0.140 |
Why?
|
| Colorectal Surgery | 1 | 2015 | 1 | 0.130 |
Why?
|
| Radiography, Thoracic | 1 | 2015 | 28 | 0.130 |
Why?
|
| Gastroenterology | 1 | 2015 | 11 | 0.130 |
Why?
|
| Hepatitis B Vaccines | 1 | 2014 | 7 | 0.130 |
Why?
|
| Guideline Adherence | 1 | 2015 | 67 | 0.130 |
Why?
|
| Hepatitis B | 1 | 2014 | 19 | 0.130 |
Why?
|
| Vaccination | 1 | 2014 | 41 | 0.130 |
Why?
|
| Esophagoscopy | 1 | 2014 | 12 | 0.130 |
Why?
|
| Barrett Esophagus | 1 | 2014 | 11 | 0.130 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2013 | 16 | 0.120 |
Why?
|
| Patient Compliance | 1 | 2015 | 164 | 0.120 |
Why?
|
| Intestines | 1 | 2014 | 107 | 0.120 |
Why?
|
| Population Surveillance | 1 | 2014 | 116 | 0.120 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2014 | 88 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2013 | 142 | 0.110 |
Why?
|
| Middle Aged | 10 | 2015 | 9823 | 0.100 |
Why?
|
| Male | 11 | 2015 | 15621 | 0.100 |
Why?
|
| Female | 11 | 2015 | 16197 | 0.100 |
Why?
|
| Aged | 8 | 2015 | 9448 | 0.090 |
Why?
|
| Neoplasm Staging | 3 | 2015 | 340 | 0.080 |
Why?
|
| Cynara scolymus | 1 | 2008 | 1 | 0.080 |
Why?
|
| Phenols | 1 | 2008 | 8 | 0.080 |
Why?
|
| Flavonoids | 1 | 2008 | 19 | 0.080 |
Why?
|
| Antioxidants | 1 | 2008 | 56 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2008 | 124 | 0.080 |
Why?
|
| Postoperative Complications | 2 | 2005 | 957 | 0.080 |
Why?
|
| Energy Intake | 2 | 2004 | 66 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2008 | 103 | 0.070 |
Why?
|
| Adult | 6 | 2014 | 8601 | 0.070 |
Why?
|
| Rats | 2 | 2008 | 854 | 0.070 |
Why?
|
| Duodenal Diseases | 1 | 2005 | 6 | 0.070 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2005 | 19 | 0.070 |
Why?
|
| Lung Transplantation | 1 | 2005 | 18 | 0.070 |
Why?
|
| Abdomen | 1 | 2004 | 11 | 0.060 |
Why?
|
| Osteomalacia | 1 | 2004 | 1 | 0.060 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2005 | 49 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2015 | 1939 | 0.060 |
Why?
|
| Developing Countries | 1 | 2004 | 22 | 0.060 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2004 | 3 | 0.060 |
Why?
|
| Short Bowel Syndrome | 1 | 2004 | 2 | 0.060 |
Why?
|
| Ergocalciferols | 1 | 1984 | 2 | 0.060 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 1984 | 6 | 0.060 |
Why?
|
| Bone Diseases, Metabolic | 1 | 1984 | 16 | 0.060 |
Why?
|
| Hepatic Encephalopathy | 1 | 2004 | 4 | 0.060 |
Why?
|
| Ghrelin | 1 | 2003 | 3 | 0.060 |
Why?
|
| Neuropeptide Y | 1 | 2003 | 3 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2015 | 145 | 0.060 |
Why?
|
| Academic Medical Centers | 2 | 2015 | 142 | 0.060 |
Why?
|
| Food, Organic | 1 | 2003 | 3 | 0.060 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2003 | 7 | 0.060 |
Why?
|
| Fractures, Bone | 1 | 2004 | 73 | 0.060 |
Why?
|
| Adjuvants, Immunologic | 1 | 2003 | 26 | 0.060 |
Why?
|
| Liver Cirrhosis | 1 | 2004 | 60 | 0.060 |
Why?
|
| Body Weight | 1 | 2003 | 133 | 0.060 |
Why?
|
| Logistic Models | 2 | 2015 | 407 | 0.060 |
Why?
|
| Insulin | 1 | 2003 | 92 | 0.060 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2002 | 1 | 0.050 |
Why?
|
| Genistein | 1 | 2002 | 3 | 0.050 |
Why?
|
| HT29 Cells | 1 | 2002 | 6 | 0.050 |
Why?
|
| Vacuoles | 1 | 2002 | 6 | 0.050 |
Why?
|
| Caco-2 Cells | 1 | 2002 | 53 | 0.050 |
Why?
|
| Cell Survival | 1 | 2002 | 169 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 2 | 2015 | 333 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2015 | 3273 | 0.050 |
Why?
|
| Length of Stay | 1 | 2003 | 317 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2013 | 638 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 553 | 0.050 |
Why?
|
| Disease Progression | 1 | 2004 | 787 | 0.050 |
Why?
|
| Prognosis | 2 | 2013 | 840 | 0.050 |
Why?
|
| Mice | 1 | 2003 | 1607 | 0.040 |
Why?
|
| Animals | 2 | 2008 | 4552 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2005 | 3478 | 0.040 |
Why?
|
| Hospitals, Community | 1 | 2015 | 14 | 0.030 |
Why?
|
| Rectal Neoplasms | 1 | 2015 | 19 | 0.030 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2014 | 10 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2014 | 15 | 0.030 |
Why?
|
| Metaplasia | 1 | 2014 | 11 | 0.030 |
Why?
|
| Stomach | 1 | 2014 | 18 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 65 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 321 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2015 | 79 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2014 | 86 | 0.030 |
Why?
|
| Esophageal Neoplasms | 1 | 2014 | 45 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2013 | 66 | 0.030 |
Why?
|
| Biopsy | 1 | 2014 | 234 | 0.030 |
Why?
|
| Sex Factors | 1 | 2015 | 496 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 521 | 0.030 |
Why?
|
| Prevalence | 1 | 2014 | 487 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 4851 | 0.030 |
Why?
|
| Age Factors | 1 | 2015 | 843 | 0.030 |
Why?
|
| Rectum | 1 | 2011 | 61 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 80 | 0.030 |
Why?
|
| Chicago | 1 | 2014 | 865 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 959 | 0.030 |
Why?
|
| Biomarkers | 1 | 2014 | 689 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2013 | 230 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 770 | 0.020 |
Why?
|
| Colon | 1 | 2011 | 148 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 1830 | 0.020 |
Why?
|
| United States | 1 | 2015 | 2333 | 0.020 |
Why?
|
| Glucose Oxidase | 1 | 2008 | 1 | 0.020 |
Why?
|
| Malondialdehyde | 1 | 2008 | 1 | 0.020 |
Why?
|
| Phenylenediamines | 1 | 2008 | 1 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2008 | 4 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2008 | 9 | 0.020 |
Why?
|
| Polyphenols | 1 | 2008 | 5 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2008 | 30 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2008 | 43 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2013 | 1811 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2008 | 170 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2008 | 198 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 264 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 437 | 0.020 |
Why?
|
| Apoptosis | 1 | 2008 | 251 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2008 | 676 | 0.020 |
Why?
|
| Duodenoscopy | 1 | 2005 | 2 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2005 | 49 | 0.020 |
Why?
|
| Forecasting | 1 | 2005 | 117 | 0.020 |
Why?
|
| Dehydration | 1 | 2004 | 4 | 0.020 |
Why?
|
| Body Water | 1 | 2004 | 5 | 0.020 |
Why?
|
| Rehydration Solutions | 1 | 2004 | 3 | 0.020 |
Why?
|
| Gastrostomy | 1 | 2004 | 8 | 0.020 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 1984 | 3 | 0.020 |
Why?
|
| Phosphorus | 1 | 1984 | 6 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 2004 | 32 | 0.020 |
Why?
|
| Parathyroid Hormone | 1 | 1984 | 23 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2004 | 33 | 0.020 |
Why?
|
| Random Allocation | 1 | 1984 | 146 | 0.010 |
Why?
|
| Bone and Bones | 1 | 1984 | 119 | 0.010 |
Why?
|
| Diet | 1 | 2004 | 174 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 402 | 0.010 |
Why?
|